FER1L6-AS1

Across TCGA pan-cancer cohorts, FER1L6-AS1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of FER1L6-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where FER1L6-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types FER1L6-AS1 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, BRCA, and THCA are the cancer types where FER1L6-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FER1L6-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.005	.002	5	view →
BRCA	All	All	+0.014	.026	2	view →
THCA	Female	II,III,IV	−0.013	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

FER1L6-AS1–KIRC

Open the KIRC breakdown →